Flare Capital Partners

Flare Capital Partners
Name	Flare Capital Partners
Type	Venture Capital Firm
Founded	2016
Founders	* Steve Kraus * Bob Kocher * Amy Abernethy
Headquarters	Boston, Massachusetts
Industry	Venture Capital, Healthcare
Products	Early-stage venture investments

Flare Capital Partners is a venture capital firm focused on early-stage investments in healthcare technology, digital health, and health services. Founded by investors and clinicians with prior experience at prominent institutions and firms, the firm seeks to bridge clinical insight with technology-driven business models. Flare Capital has participated in multiple funding rounds across telemedicine, digital therapeutics, healthcare data, and practice management platforms.

History

Flare Capital Partners was founded in 2016 by a team including Steve Kraus, Bob Kocher, and Amy Abernethy after their tenures and collaborations with organizations such as NEA (New Enterprise Associates), MGH (Massachusetts General Hospital), and Stanford University School of Medicine. Early activity occurred amid growth in telemedicine and digital health startups catalyzed by venture firms like Sequoia Capital, Andreessen Horowitz, and Bessemer Venture Partners. The firm established offices in Boston, Massachusetts and expanded networks into San Francisco, California and New York City. Flare Capital launched initial funds during a period influenced by policy shifts at Centers for Medicare & Medicaid Services and innovation initiatives at National Institutes of Health. The firm’s timeline includes investments tied to accelerators and incubators such as Y Combinator, Rock Health, and Plug and Play Tech Center while navigating market cycles that affected peers including Oak HC/FT, General Catalyst, and Polaris Partners.

Investment Strategy and Focus

Flare Capital targets early-stage companies operating at the intersection of clinical care and technology, emphasizing business models that engage stakeholders like hospital systems such as Brigham and Women’s Hospital, Cleveland Clinic, and Kaiser Permanente. The firm focuses on segments including telehealth platforms comparable toTeladoc Health, digital therapeutics similar to Pear Therapeutics, healthcare data platforms in the vein of Flatiron Health, and practice management solutions like Athenahealth. Its investment thesis considers regulatory environments influenced by Food and Drug Administration (FDA), reimbursement frameworks from Centers for Medicare & Medicaid Services and private payers like UnitedHealth Group, CVS Health, and Cigna. Flare Capital applies clinical validation, outcomes measurement, and payer adoption as decision criteria informed by research from institutions such as Harvard Medical School, Johns Hopkins University, and Mayo Clinic.

Notable Investments and Exits

Flare Capital’s portfolio has included companies across telehealth, health data, and care delivery platforms, participating in rounds alongside investors like NEA (New Enterprise Associates), GV (formerly Google Ventures), and Bain Capital Ventures. Notable investments have involved startups in the vein of Circle Medical, Collective Health, Omada Health, and Zocdoc-style marketplaces, with strategic exits or follow-on financings drawing participation from private equity firms such as Silver Lake and TPG. Portfolio companies have engaged in partnerships with healthcare systems including Mount Sinai Health System, Massachusetts General Hospital, and Partners HealthCare and pursued regulatory clearances with the Food and Drug Administration (FDA). Flare Capital-backed exits have resulted in acquisitions by corporate buyers in biotechnology and health services sectors similar to Roche, UnitedHealth Group, and Anthem, Inc..

Team and Leadership

Leadership at Flare Capital has combined clinical leaders and experienced investors. Founders and senior partners draw on backgrounds at NEA (New Enterprise Associates), Google, academic institutions like Harvard Medical School and Stanford University School of Medicine, and healthcare organizations such as Massachusetts General Hospital and Dartmouth-Hitchcock Medical Center. The team includes investors with operating experience from firms like Sequoia Capital, Bessemer Venture Partners, and General Catalyst, and advisors from healthcare companies including Teladoc Health, CVS Health, and GE Healthcare. Flare Capital’s network extends to entrepreneurs previously associated with startups accelerated by Y Combinator, 500 Startups, and Rock Health, and to clinicians who have served on editorial boards of journals like The New England Journal of Medicine and JAMA.

Fundraising and Financials

Since inception, Flare Capital has raised multiple funds targeting early-stage healthcare technology companies, with limited partners including family offices, endowments such as Harvard Management Company, and institutional investors similar to CalPERS and Yale Investments Office. Fund sizes reflect market dynamics driven by healthcare venture flows observed at firms like Oak HC/FT and General Catalyst, and the firm has co-invested with corporate venture arms including Google Ventures and Johnson & Johnson Innovation. Portfolio follow-on rounds have attracted participation from late-stage investors such as SoftBank and Accel Partners, and the firm monitors key performance indicators aligned with standards used by Cambridge Associates and PitchBook.

Industry Impact and Recognition

Flare Capital has been cited in industry coverage by publications such as The Wall Street Journal, The New York Times, Forbes, Bloomberg, and sector outlets like STAT News and FierceHealthcare. The firm is recognized among healthcare-focused investors alongside Oak HC/FT, SR One, and Third Rock Ventures for promoting clinical entrepreneurship and supporting startups that address care delivery transformation and digital therapeutics. Flare Capital partners have participated in panels at conferences hosted by HLTH, J.P. Morgan Healthcare Conference, Health 2.0, and HIMSS, and have advised policy discussions involving agencies such as Centers for Medicare & Medicaid Services and Food and Drug Administration (FDA). The firm’s portfolio companies have received awards and validation from organizations including Rock Health, FierceHealthcare, and industry competitions affiliated with SXSW and HLTH.

Category:Venture capital firms